Patients News | pharmaphorum

News

Young adults regret health decisions based on bad info

Almost half of young adults in the UK have said they made a health decision they regret based on misinformation, often from online content creators.

News

Sarepta bags key expansion to DMD gene therapy label in US

Sarepta’s gene therapy for Duchenne muscular dystrophy (DMD) will be an option for many more patients in the US after the FDA expanded the breadth of its approved labelling.

News

Sanofi: NICE would reject Sarclisa even if it cost nothing

Sanofi has hit back on a decision by NICE not to recommend NHS use of Sarclisa as part of a regimen for relapsed and refractory multiple myeloma (RRMM), claiming the agency would not consid

News

Infectious disease group ISID names six global priorities

The non-profit International Society for Infectious Diseases (ISID) has published a set of six priorities focusing on the challenges faced by low- and middle-income countries (LMICs) ahead

News

Blood test could spot Parkinson’s years earlier

An artificial intelligence-powered blood test that may be able to predict Parkinson’s disease several years before symptoms start to develop could allow earlier treatment and help guide the

News

Amazon extends $5 generic subscription service to Medicare

Amazon’s pharmacy division is expanding its $5-per-month subscription service for generic medicines, making it available for patients enrolled in Medicare.

Young adults regret health decisions based on bad info

Sarepta bags key expansion to DMD gene therapy label in US

Sanofi: NICE would reject Sarclisa even if it cost nothing

Infectious disease group ISID names six global priorities

Blood test could spot Parkinson’s years earlier

Amazon extends $5 generic subscription service to Medicare

Making direct-to-patient work, with Matt Wadyka

Using AI-driven synthetic personas to take your insights fur...

News

Editor's Picks